181 related articles for article (PubMed ID: 21069104)
1. Botulinum toxin: a poison transformed into a versatile tool.
Mahajan S; Srivastava V
Eur J Esthet Dent; 2010; 5(4):327-9. PubMed ID: 21069104
[No Abstract] [Full Text] [Related]
2. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
Bhidayasiri R; Cardoso F; Truong DD
Eur J Neurol; 2006 Feb; 13 Suppl 1():21-9. PubMed ID: 16417594
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin treatment of axial and cervical dystonia.
Benecke R; Dressler D
Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
[TBL] [Abstract][Full Text] [Related]
4. Reply: Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: randomized, double-blind, noninferiority trial.
Mueller J
Mov Disord; 2009 May; 24(7):1098-9; author reply 1100. PubMed ID: 18942082
[No Abstract] [Full Text] [Related]
5. Botulinum toxin therapy of hemifacial spasm: comparing different therapeutic preparations.
Frei K; Truong DD; Dressler D
Eur J Neurol; 2006 Feb; 13 Suppl 1():30-5. PubMed ID: 16417595
[TBL] [Abstract][Full Text] [Related]
6. The changed image of botulinum toxin.
Misra VP
BMJ; 2002 Nov; 325(7374):1188. PubMed ID: 12446514
[No Abstract] [Full Text] [Related]
7. Botulinum toxin as a therapeutic agent.
Tsui JK
Pharmacol Ther; 1996; 72(1):13-24. PubMed ID: 8981568
[TBL] [Abstract][Full Text] [Related]
8. Botox and Dysport are distinct.
Madaliński M
Endoscopy; 2000 Jun; 32(6):502-3. PubMed ID: 10863924
[No Abstract] [Full Text] [Related]
9. Botulinum toxin: potent poison, potent medicine.
Simpson LL
Hosp Pract (1995); 1999 Apr; 34(4):87-91; quiz 163. PubMed ID: 10212633
[TBL] [Abstract][Full Text] [Related]
10. Medical therapy and botulinum toxin in dystonia.
Jankovic J
Adv Neurol; 1998; 78():169-83. PubMed ID: 9750914
[No Abstract] [Full Text] [Related]
11. Treatment of spasticity with botulinum toxin.
Simpson DM
Muscle Nerve; 2000 Apr; 23(4):447-9. PubMed ID: 10716753
[No Abstract] [Full Text] [Related]
12. [Botulinum toxin in the treatment of spasticity].
Arriola-Arellano E; Chacón J; Alvarez-López M; Balbuena-García M; Fuentes-Pradera J; Vicente-Baz D
Rev Neurol; 2006 Feb 16-28; 42(4):250-1. PubMed ID: 16521066
[No Abstract] [Full Text] [Related]
13. The current use of botulinum toxin.
Mahant N; Clouston PD; Lorentz IT
J Clin Neurosci; 2000 Sep; 7(5):389-94. PubMed ID: 10942658
[TBL] [Abstract][Full Text] [Related]
14. [Treatment with botulinum toxin in neurologic pediatrics].
Justus N; Lee SH; Berweck S; Heinen F
Kinderkrankenschwester; 2007 Jul; 26(7):274-6. PubMed ID: 17726921
[No Abstract] [Full Text] [Related]
15. Immediate response to botulinum toxin injections in patients with fixed dystonia.
Edwards MJ; Bhatia KP; Cordivari C
Mov Disord; 2011 Apr; 26(5):917-8. PubMed ID: 21394784
[No Abstract] [Full Text] [Related]
16. Botulinum toxins: pharmacology and its current therapeutic evidence for use.
Panicker JN; Muthane UB
Neurol India; 2003 Dec; 51(4):455-60. PubMed ID: 14742921
[TBL] [Abstract][Full Text] [Related]
17. Chemodenervation with botulinum toxin for spasticity and dystonia. The effects on gait.
O'Brien CF
Adv Neurol; 2001; 87():265-9. PubMed ID: 11347231
[No Abstract] [Full Text] [Related]
18. Botulinum toxin. From poison to medical wonder.
Mayo Clin Health Lett; 2006 Dec; 24(12):4-5. PubMed ID: 17310508
[No Abstract] [Full Text] [Related]
19. [Use of botulinum toxin in ophthalmology: current concepts and problems].
Tapiero B; Robert PY; Adenis JP; Riss I
J Fr Ophtalmol; 1997; 20(2):134-45. PubMed ID: 9099272
[No Abstract] [Full Text] [Related]
20. The use of botulinum toxin in head and neck disorders.
Hawthorne MR
Hosp Med; 2003 Aug; 64(8):460-3. PubMed ID: 12958756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
